New oral medicines are showing great promise in slowing down the progression of COVID-19 and preventing the need for intensive medical care, says Ministry of Health chief science advisor Ian Town
Pharmac’s drug buying approach disadvantages Māori, Pacific people, disabled people, those living with rare disorders and does little to reduce inequity.
Pharmac’s chief medical officer Dr David Hughes has today announced the decision to fund a biosimilar adalimumab (Amgevita), improving access to adalimumab for more than 700 New Zealanders
Specialist GP Nikki Vadgama provides some tips to make your next paediatric eczema consult easier. She includes a review of new guidelines, resources, websites and medications for paediatric eczema management